Celgene Corporation (Public, NASDAQ:CELG) Gilead Sciences Completes Acquisition of Raylo Chemicals Inc. and Celgene Announces Pricing of Common Stock Offering
Biotechnology industry news Gilead Sciences, Inc. (Nasdaq:GILD) recently announced that the company has completed its acquisition of Raylo Chemicals Inc., a subsidiary of Germany-based specialty chemicals company Degussa AG, for approximately 107 million euros. Gilead intends to utilize this Edmonton, Alberta-based site for process research and scale-up of clinical development candidates, for manufacturing of active pharmaceutical ingredients (API) for both investigational and commercial products and for chemical development activities to improve existing commercial manufacturing processes. PDL BioPharma Inc. (Nasdaq:PDLI) said Thursday it posted a narrower third-quarter loss as revenue jumped 44 percent in large part on gains from a severed collaboration with Roche. The company lost $6.7 million, or 6 cents per share, compared with a loss of $45.2 million, or 43 cents per share, a year ago. Analysts polled by Thomson Financial expected a loss of 1-cent per share. Celgene Corporation (Nasdaq: CELG), announced the pricing of its public offering of 20,000,000 shares of its common stock at a public offering price of $51.60 per share. The gross proceeds of the offering will be $1.032 billion. This offering of the shares of Celgene common stock may be made only by means of a prospectus. Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company. NutraCea, (OTC BB: NTRZ) the world leader in stabilized rice bran technology, is pleased to announce that its Chief Executive Officer, Mr. Brad Edson, is scheduled to present at the Rodman & Renshaw 8th Annual Healthcare Conference on November 6, 2006 at 9:10 a.m. EST. The three-day conference is being held at the New York Palace in New York City and will include presentations by over 300 companies, as well as experts from the medical, scientific and investment communities. http://tech.groups.yahoo.com/group/biotech-news/ http://www.arizonabiotech.com/ http://www.azhttp.com/ http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> Your email settings: Individual Email | Traditional <*> To change settings online go to: http://groups.yahoo.com/group/biotech-news/join (Yahoo! ID required) <*> To change settings via email: mailto:[EMAIL PROTECTED] mailto:[EMAIL PROTECTED] <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
